• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质-蛋白质相互作用位点的定位与表征

Localization and characterization of protein-protein interaction sites.

作者信息

Singh Chingakham Ranjit, Asano Katsura

机构信息

Molecular, Cellular, and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, Kansas, USA.

出版信息

Methods Enzymol. 2007;429:139-61. doi: 10.1016/S0076-6879(07)29007-X.

DOI:10.1016/S0076-6879(07)29007-X
PMID:17913622
Abstract

This chapter aims to describe methods to identify and characterize protein-protein interactions that were developed during our studies on translation initiation factor complexes. Methods include the two-hybrid assay, the GST pull-down assay, and the coimmunoprecipitation (co-IP) assay. The two-hybrid assay provides for a convenient start to find the minimal interaction domains, which generally produce well-behaved recombinant proteins suited for various in vitro interaction assays. Emphasis is placed on demonstrating physiological relevance of identified interactions. The effective strategy is to find mutations that reduce the interaction by genetic or site-directed mutational approaches and obtain correlations between their effects in vitro (GST pull down) and effects in vivo (co-IP).

摘要

本章旨在描述我们在对翻译起始因子复合物的研究过程中开发的用于鉴定和表征蛋白质-蛋白质相互作用的方法。这些方法包括双杂交测定、GST下拉测定和免疫共沉淀(co-IP)测定。双杂交测定为寻找最小相互作用结构域提供了便利的开端,该结构域通常会产生适用于各种体外相互作用测定的性能良好的重组蛋白。重点在于证明所鉴定相互作用的生理相关性。有效的策略是通过遗传或定点突变方法找到能降低相互作用的突变,并获得它们在体外(GST下拉)和体内(co-IP)效应之间的相关性。

相似文献

1
Localization and characterization of protein-protein interaction sites.蛋白质-蛋白质相互作用位点的定位与表征
Methods Enzymol. 2007;429:139-61. doi: 10.1016/S0076-6879(07)29007-X.
2
Characterization of an intramolecular protein-protein interaction in c-Ets1 and its viral homologue v-Ets.c-Ets1及其病毒同源物v-Ets中分子内蛋白质-蛋白质相互作用的表征
Oncol Rep. 2007 Aug;18(2):457-63.
3
Analysis of the interaction between cytohesin 2 and IPCEF1.细胞衔接蛋白2与IPCEF1之间相互作用的分析
Methods Enzymol. 2005;404:252-66. doi: 10.1016/S0076-6879(05)04024-3.
4
Glutathione-S-transferase-fusion based assays for studying protein-protein interactions.用于研究蛋白质-蛋白质相互作用的基于谷胱甘肽-S-转移酶融合的检测方法。
Methods Mol Biol. 2004;261:175-86. doi: 10.1385/1-59259-762-9:175.
5
Study of G-protein-coupled receptor-protein interactions using gel overlay assays and glutathione-S-transferase-fusion protein pull-downs.利用凝胶覆盖分析和谷胱甘肽-S-转移酶融合蛋白下拉技术研究G蛋白偶联受体-蛋白相互作用
Methods Mol Biol. 2004;259:371-8. doi: 10.1385/1-59259-754-8:371.
6
A computationally guided protein-interaction screen uncovers coiled-coil interactions involved in vesicular trafficking.一项计算机辅助的蛋白质相互作用筛选揭示了囊泡运输中涉及的卷曲螺旋相互作用。
J Mol Biol. 2009 Sep 11;392(1):228-41. doi: 10.1016/j.jmb.2009.07.006. Epub 2009 Jul 8.
7
Quantitative assessment of the structural bias in protein-protein interaction assays.蛋白质-蛋白质相互作用检测中结构偏差的定量评估。
Proteomics. 2008 Nov;8(22):4657-67. doi: 10.1002/pmic.200800150.
8
Molecular genetic structure-function analysis of translation initiation factor eIF5B.翻译起始因子eIF5B的分子遗传结构-功能分析
Methods Enzymol. 2007;429:185-201. doi: 10.1016/S0076-6879(07)29009-3.
9
The N-terminal lysine residue-rich domain II and the 340-430 amino acid segment of eukaryotic initiation factor 2-associated glycoprotein p67 are the binding sites for the gamma-subunit of eIF2.真核生物起始因子2相关糖蛋白p67富含N端赖氨酸残基的结构域II以及340 - 430氨基酸片段是eIF2γ亚基的结合位点。
Exp Cell Res. 2006 Oct 1;312(16):3184-203. doi: 10.1016/j.yexcr.2006.03.034. Epub 2006 Jun 21.
10
Analysis of phosphorylation of YJL084c, a yeast protein.酵母蛋白YJL084c的磷酸化分析
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Jul;34(4):433-8.

引用本文的文献

1
Characterization of the E26H Mutant Schistosoma japonicum Glutathione S-Transferase.日本血吸虫谷胱甘肽S-转移酶E26H突变体的特性分析
Proteins. 2025 May;93(5):1054-1066. doi: 10.1002/prot.26794. Epub 2025 Jan 2.
2
Tagging Recombinant Proteins to Enhance Solubility and Aid Purification.标记重组蛋白以提高其可溶性并辅助其纯化。
Methods Mol Biol. 2023;2699:97-123. doi: 10.1007/978-1-0716-3362-5_7.
3
Label-free protocol to quantify protein affinity using isothermal titration calorimetry and bio-layer interferometry of a human eIF5-mimic protein.
无标记协议,使用等温滴定量热法和生物层干涉法对人 eIF5 模拟蛋白进行蛋白质亲和力定量。
STAR Protoc. 2022 Aug 16;3(3):101615. doi: 10.1016/j.xpro.2022.101615. eCollection 2022 Sep 16.
4
Human oncoprotein 5MP suppresses general and repeat-associated non-AUG translation via eIF3 by a common mechanism.人类癌蛋白5MP通过一种共同机制,经由真核起始因子3(eIF3)抑制一般翻译和重复序列相关的非AUG起始的翻译。
Cell Rep. 2021 Jul 13;36(2):109376. doi: 10.1016/j.celrep.2021.109376.
5
Sequential eukaryotic translation initiation factor 5 (eIF5) binding to the charged disordered segments of eIF4G and eIF2β stabilizes the 48S preinitiation complex and promotes its shift to the initiation mode.顺序真核翻译起始因子 5(eIF5)与 eIF4G 和 eIF2β 的带电无序片段结合,稳定 48S 起始前复合物,并促进其向起始模式转变。
Mol Cell Biol. 2012 Oct;32(19):3978-89. doi: 10.1128/MCB.00376-12. Epub 2012 Jul 30.
6
Mechanisms of translational regulation by a human eIF5-mimic protein.人 eIF5 模拟蛋白的翻译调控机制。
Nucleic Acids Res. 2011 Oct;39(19):8314-28. doi: 10.1093/nar/gkr339. Epub 2011 Jul 10.
7
Purification of proteins fused to glutathione S-transferase.与谷胱甘肽S-转移酶融合的蛋白质的纯化。
Methods Mol Biol. 2011;681:259-80. doi: 10.1007/978-1-60761-913-0_14.
8
Yeast 18 S rRNA is directly involved in the ribosomal response to stringent AUG selection during translation initiation.酵母 18S rRNA 直接参与核糖体对翻译起始时严格 AUG 选择的反应。
J Biol Chem. 2010 Oct 15;285(42):32200-12. doi: 10.1074/jbc.M110.146662. Epub 2010 Aug 10.
9
The eukaryotic initiation factor (eIF) 4G HEAT domain promotes translation re-initiation in yeast both dependent on and independent of eIF4A mRNA helicase.真核起始因子 (eIF) 4G HEAT 结构域促进酵母中依赖和不依赖于 eIF4A mRNA 解旋酶的翻译重新起始。
J Biol Chem. 2010 Jul 16;285(29):21922-33. doi: 10.1074/jbc.M110.132027. Epub 2010 May 12.